Doctors Note Logo

Published on: 9/24/2026

Is Gwyn Lo a birth control patch, and how is it worn?

Gwyn Lo is a combination hormonal contraceptive worn as a transdermal patch, delivering estrogen and progestin through the skin to prevent pregnancy. It is pressed onto clean, dry, hairless skin on the upper outer arm, abdomen, buttock, or upper torso (never the breasts), then swapped for a fresh patch on the same day each week for three weeks, followed by one patch-free week. Correct placement, rotating sites, backup contraception timing, and what to do if a patch loosens or falls off all change how well it protects you, so review the important details below before relying on it. If you are dealing with spotting, nausea, headaches, breast tenderness, or mood changes while using the patch, a free, instant, online symptom check can help you sort out what is likely behind it in just a

answer background

Explanation

Is “Gwyn Lo Patch” a Birth Control Patch?
No. There is no FDA-approved contraceptive called the “Gwyn Lo patch.” If you’ve heard this name in conversation or online, it likely refers to a misunderstanding or misspelling of established birth control patches such as Xulane (formerly Ortho Evra) or Twirla. Below, you’ll find clear, reliable information on how hormonal contraceptive patches work and how they’re worn.


What Is a Birth Control Patch?

A birth control patch is a small, sticky skin patch that releases two hormones—an estrogen (ethinyl estradiol) and a progestin—into your bloodstream. These hormones prevent ovulation (the release of an egg), thicken cervical mucus to block sperm, and thin the uterine lining to reduce the chance of implantation.

Common brand names include:

  • Xulane (norelgestromin / ethinyl estradiol)
  • Twirla (levonorgestrel / ethinyl estradiol)

Despite similar ingredients and action, there is no “gwyn lo patch” on the market. Always check for FDA approval and talk with your pharmacist or provider if you’re unsure about a product name.


How the Patch Works

Once applied, the patch delivers a steady dose of hormones:

  • Suppresses ovulation: Your body stops releasing eggs monthly.
  • Thickens cervical mucus: Sperm have a harder time entering the uterus.
  • Thins the uterine lining: Reduces the chance that a fertilized egg can implant.

When used correctly, the patch is over 99% effective at preventing pregnancy. Typical use effectiveness is around 91%, largely due to human error (forgetting to change the patch on time, applying it improperly, etc.).


How to Wear a Birth Control Patch

  1. Choose an application site.

    • Upper outer arm
    • Buttock
    • Abdomen (except the area around your navel)
    • Upper torso (front or back, excluding breasts)
  2. Prep your skin.

    • Clean and dry the area.
    • Avoid lotions, oils, powders, or any product that might prevent good adhesion.
    • Do not apply to irritated, cut, or sunburned skin.
  3. Apply the patch.

    • Open the pouch carefully; do not cut the patch.
    • Peel off half the backing and place the sticky side on your skin.
    • Peel off the rest of the backing and press firmly for 10 seconds, especially around the edges.
  4. Follow a weekly schedule.

    • Week 1: Apply on Day 1 of your menstrual cycle (the first day of bleeding).
    • Change on the same day each week (e.g., Monday) for three consecutive weeks.
    • Week 4: No patch (this is your “patch-free” week; you may get your period during this time).
    • After week 4, restart with a new patch on Day 1 of the next cycle.
  5. Rotate sites.

    • Use a different application site each week to reduce skin irritation.
    • After three weeks, you can re-use sites from week 1 if they’re fully healed.

What to Do If Your Patch Falls Off

  • Less than 24 hours:

    • Try to reapply the same patch or replace it with a new one immediately.
    • Continue your regular patch change schedule.
  • More than 24 hours:

    • Start a new weekly cycle with a fresh patch immediately (consider this “Day 1” of week 1).
    • Use a backup method (e.g., condoms) for the next 7 days.

If patches routinely peel off, check your skin prep routine and consider an alternative site.


Common Side Effects

Most side effects are mild and often improve after 1–2 months:

  • Skin irritation or rash at the application site
  • Breast tenderness or swelling
  • Headache
  • Nausea
  • Spotting or light breakthrough bleeding

When to seek medical attention:

  • Severe abdominal pain or chest pain
  • Shortness of breath
  • Sudden severe headache or vision changes
  • Leg pain or swelling (signs of blood clots)

These symptoms could be signs of a serious condition. If you experience any, remove the patch and call your doctor right away.


Benefits Beyond Pregnancy Prevention

  • Lighter, more predictable periods
  • Reduced menstrual cramps
  • Improvement in acne for some users
  • Easy, once-a-week dosing

Important Considerations

  • Not for everyone. Smokers over age 35, people with certain blood‐clotting disorders, high blood pressure, or a history of stroke should avoid estrogen-containing patches.
  • Drug interactions. Some seizure, HIV, and tuberculosis medications can make the patch less effective. Always review all your prescriptions with your provider.
  • Missed doses. Missing or delaying patch changes can lead to breakthrough bleeding or unintended pregnancy.

If you’re ever unsure about a symptom or drug interaction, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide if you need professional care and guide your next steps.


Key Takeaways

  • There is no birth control product named the “gwyn lo patch.”
  • Birth control patches like Xulane and Twirla deliver hormones through the skin, preventing pregnancy when used correctly.
  • Apply once weekly for three weeks, then take one week off. Rotate sites and follow instructions closely.
  • Monitor for side effects; seek help for any sign of a blood clot or other serious reaction.
  • Talk openly with your healthcare provider about your options and any concerns.

Always speak to a doctor about any serious or life-threatening issues, or if you have questions about your risk factors and the best contraceptive method for you.

(References)

  • * Yonkers KA, O'Brien PM, Eriksson E. Premenstrual syndrome. Lancet. 2008 Apr 5;371(9619):1200-10. doi: 10.1016/S0140-6736(08)60527-9. PMID: 18395582; PMCID: PMC3118460.

  • * Peck SA. Long-acting reversible contraception. Nurs Womens Health. 2013 Oct;17(5):431-5. doi: 10.1111/1751-486X.12066. PMID: 24138662.

  • * Colquitt CW, Martin TS. Contraceptive Methods. J Pharm Pract. 2017 Feb;30(1):130-135. doi: 10.1177/0897190015585751. Epub 2016 Jul 8. PMID: 26033795.

  • * Lobert M, Pigeyre M, Gronier H, Catteau-Jonard S, Robin G. [Contraception and obesity]. Gynecol Obstet Fertil. 2015 Nov;43(11):740-7. doi: 10.1016/j.gyobfe.2015.09.009. Epub 2015 Oct 31. PMID: 26527416.

  • * Choice of contraceptives. Med Lett Drugs Ther. 2018 Oct 8;60(1557):161-168. PMID: 30335731.

  • * Grandi G, Barra F, Ferrero S, Sileo FG, Bertucci E, Napolitano A, Facchinetti F. Hormonal contraception in women with endometriosis: a systematic review. Eur J Contracept Reprod Health Care. 2019 Feb;24(1):61-70. doi: 10.1080/13625187.2018.1550576. Epub 2019 Jan 21. PMID: 30664383.

  • * Le Guen M, Schantz C, Régnier-Loilier A, de La Rochebrochard E. Reasons for rejecting hormonal contraception in Western countries: A systematic review. Soc Sci Med. 2021 Sep;284:114247. doi: 10.1016/j.socscimed.2021.114247. Epub 2021 Jul 20. PMID: 34339927.

  • * Nguyen AT, Curtis KM, Tepper NK, Kortsmit K, Brittain AW, Snyder EM, Cohen MA, Zapata LB, Whiteman MK, Contributors. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024 Aug 8;73(4):1-126. doi: 10.15585/mmwr.rr7304a1. Epub 2024 Aug 8. PMID: 39106314; PMCID: PMC11315372.

  • * Skeith L, Bates SM. Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices. Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):644-651. doi: 10.1182/hematology.2024000591. PMID: 39644023; PMCID: PMC11665608.

  • * Plu-Bureau G, Raccah-Tebeka B. [Contraception and thrombophilia]. Rev Prat. 2025 Mar;75(3):290-292. PMID: 40546174.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.